http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 09 Jan 2026 07:00:32 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html <p>Pulse Biosciences Inc. (NASDAQ: PLSE) appointed Maria Sainz to its board of directors effective January 9, 2026, according to a company statement.</p> <p>Sainz brings more than 30 years of healthcare technology experience, including 18 years in chief executive roles at publicly traded companies and venture-backed startups. She currently serves as president and CEO of Hyperfine Inc. (NASDAQ: HYPR), a medical technology company with a portable brain MRI system.</p> <p>Previously, Sainz held CEO positions at Aegea Medical, CardioKinetix Inc., and Concentric Medical. She also served in leadership roles at Guidant Corporation and Boston Scientific Corporation, including as president of the Cardiac Surgery Division http://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html Fri, 09 Jan 2026 07:00:32 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html <p> HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. </p><p> “We are delighted to welcome Maria to our Board of Directors,” said Pulse Biosciences’ Co-Chairman of the Board Robert W. Duggan. “She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse http://www.streetinsider.com/Press+Releases/Pulse+Biosciences%2C+Inc.+Appoints+Maria+Sainz+to+its+Board+of+Directors/25829055.html Fri, 09 Jan 2026 07:00:00 -0500 A.01676725 A.07275829 A.29373378 AVNS HYPR O.00811666 O.05085444 O.11570143 O.18720149 O.19947484 O.19960613 O.28943335 OFIX PLSE S2WA34 SPNC SWAV